SCHEMBL32682886

SCHEMBL32682886

CS(=O)(=O)Nc1nnc(Cl)cc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JUN P05412 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ KIF11 P52732 3/20 0.39
▸ CYP17A1 P05093 3/20 0.36
▸ SLC22A12 Q96S37 1/20 0.36
▸ NOTUM Q6P988 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.33
▸ CCR2 P41597 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ CCR4 P51679 1/20 0.33
▸ GLP1R P43220 1/20 0.33
▸ SSTR4 P31391 1/20 0.32
▸ EDNRA P25101 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30529582 0.74 JUN (0.41) JUNNFKB1NFKB2RELAPOLB
SCHEMBL10204269 0.74 JUN (0.41) JUNNFKB1NFKB2RELAPOLB
Hydrochloric Acid SCHEMBL1204256 0.73 JUN (0.40) JUNNFKB1NFKB2RELAPOLB
SCHEMBL15688040 0.72 JUN (0.50) JUNNFKB1NFKB2RELAHTT
SCHEMBL15687760 0.70 JUN (0.45) JUNNFKB1NFKB2RELAPOLB
SCHEMBL22654976 0.68 IL1B (0.52) JUNNFKB1NFKB2RELANOTUM
SCHEMBL30869557 0.67 CYP17A1 (0.36) KIF11CYP17A1SLC22A12POLBLMNA
SCHEMBL29708780 0.67 TDP1 (0.44) JUNNFKB1NFKB2RELANOTUM
SCHEMBL1204974 0.67 TDP1 (0.44) JUNNFKB1NFKB2RELANOTUM
SCHEMBL31518585 0.66 HPGD (0.47) LMNAHTTL3MBTL1GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260070880-A1 DYNAMIN ACTIVATORS WALDEN BIOSCIENCES, INC. (US) 2026-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260070880-A1 DYNAMIN ACTIVATORS DNM1, DNM1L, DNM2 JUN 3635/4885NFKB1 2564/4885NFKB2 2799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback